1. Home
  2. Labeler Index
  3. Nucare Pharmaceuticals, Inc.
  4. 68071-3175
  5. NDC Package Code: 68071-3175-4 Clindamycin Hydrochloride

NDC Package 68071-3175-4 Clindamycin Hydrochloride

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68071-3175-4
Package Description:
4 CAPSULE in 1 BOTTLE
Product Code:
68071-3175
Proprietary Name:
Clindamycin Hydrochloride
Usage Information:
Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be re­served for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of co­li­tis, as described in the  WARNING box, before selecting clindamycin, the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Serious respiratory tract infections such as empyema, anaerobic pneumonitis, and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection. Streptococci: Serious respiratory tract infections; serious skin and soft tissue infections. Staphylococci: Serious respiratory tract infections; serious skin and soft tissue infections. Pneumococci: Serious respiratory tract infections. Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin.To reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin hydrochloride and other antibacterial drugs, clindamycin hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
11-Digit NDC Billing Format:
68071317504
NDC to RxNorm Crosswalk:
  • RxCUI: 197518 - clindamycin HCl 150 MG Oral Capsule
  • RxCUI: 197518 - clindamycin 150 MG Oral Capsule
  • RxCUI: 197518 - clindamycin (as clindamycin HCl) 150 MG Oral Capsule
    • Labeler Name:
    Nucare Pharmaceuticals, Inc.
    Sample Package:
    No
    Start Marketing Date:
    07-31-1991
    Listing Expiration Date:
    12-31-2022
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    68071-3175-66 CAPSULE in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68071-3175-4?

    The NDC Packaged Code 68071-3175-4 is assigned to a package of 4 capsule in 1 bottle of Clindamycin Hydrochloride, labeled by Nucare Pharmaceuticals, Inc.. The product's dosage form is and is administered via form.

    Is NDC 68071-3175 included in the NDC Directory?

    No, Clindamycin Hydrochloride with product code 68071-3175 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Nucare Pharmaceuticals, Inc. on July 31, 1991 and its listing in the NDC Directory is set to expire on December 31, 2022 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 68071-3175-4?

    The 11-digit format is 68071317504. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-168071-3175-45-4-268071-3175-04